A citation-based method for searching scientific literature

Glenwood Goss, Chun-Ming Tsai, Frances A Shepherd, Lyudmila Bazhenova, Jong Seok Lee, Gee-Chen Chang, Lucio Crino, Miyako Satouchi, Quincy Chu, Toyoaki Hida, Ji-Youn Han, Oscar Juan, Frank Dunphy, Makoto Nishio, Jin-Hyoung Kang, Margarita Majem, Helen Mann, Mireille Cantarini, Serban Ghiorghiu, Tetsuya Mitsudomi. Lancet Oncol 2016
Times Cited: 368



J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson. Science 2004
Times Cited: 7196




List of shared articles



Times cited

Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFRL858R/T790M inhibitors.
Jianheng Li, Baijiao An, Xianheng Song, Qianzhong Zhang, Chun Chen, Shuxian Wei, Runzhu Fan, Xingshu Li, Yong Zou. Eur J Med Chem 2021
1

Quantification of BIM mRNA in circulating tumor cells of osimertinib-treated patients with EGFR mutation-positive lung cancer.
Kazutoshi Isobe, Takahiro Yoshizawa, Muneyuki Sekiya, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Takuma Isshiki, Susumu Sakamoto, Yujiro Takai, Taichiro Tomida,[...]. Respir Investig 2021
1

Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment.
Ulrich Jarry, Mégane Bostoën, Raphaël Pineau, Laura Chaillot, Valentine Mennessier, Pierre Montagne, Emilie Motte, Marjorie Gournay, Arnaud Le Goff, Thierry Guillaudeux,[...]. BMC Cancer 2021
2

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.
Luwei Han, Xiaomeng Zhang, Zhiqiang Wang, Xian Zhang, Liwen Zhao, Wei Fu, Xiaobo Liang, Zhibo Zhang, Yong Wang. Front Pharmacol 2021
0

0

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies.
Karam Khaddour, Sushma Jonna, Alexander Deneka, Jyoti D Patel, Mohamed E Abazeed, Erica Golemis, Hossein Borghaei, Yanis Boumber. Cancers (Basel) 2021
4

Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets.
Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi. Onco Targets Ther 2021
0

Genomics and the History of Precision Oncology.
Deborah B Doroshow, James H Doroshow. Surg Oncol Clin N Am 2020
5

Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer.
Chennianci Zhu, Weihao Zhuang, Limin Chen, Wenyu Yang, Wen-Bin Ou. Transl Lung Cancer Res 2020
7


A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC.
Minji Lim, Juhee Park, Alarice C Lowe, Hyoung-Oh Jeong, Semin Lee, Hee Chul Park, Kyusang Lee, Gwang Ha Kim, Mi-Hyun Kim, Yoon-Kyoung Cho. Theranostics 2020
4